Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3709877014 | Etamsylate-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3709878016 | Product containing etamsylate in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Etamsylate-containing product in oral dose form | Is a | Haemostatic agent | true | Inferred relationship | Some | ||
| Etamsylate-containing product in oral dose form | Plays role | Haemostatic therapeutic role | true | Inferred relationship | Some | ||
| Etamsylate-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Etamsylate-containing product in oral dose form | Is a | Etamsylate-containing product | true | Inferred relationship | Some | ||
| Etamsylate-containing product in oral dose form | Has active ingredient | Etamsylate | true | Inferred relationship | Some | 1 | |
| Etamsylate-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Etamsylate only product in oral dose form | Is a | True | Etamsylate-containing product in oral dose form | Inferred relationship | Some | |
| Etamsylate- and tranexamic acid-containing product in oral dose form | Is a | True | Etamsylate-containing product in oral dose form | Inferred relationship | Some | |
| Etamsylate 500 mg oral tablet | Is a | False | Etamsylate-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR